Bravecto® chewable tablets for dogs
Bravecto Chewable Tablets are indicated for the treatment of important ectoparasites of dogs including fleas, ticks and for Sarcoptes and Demodex mites. Based on the isoxazoline active ingredient, fluralaner, a duration of efficacy for both fleas and ticks has been demonstrated for up to 12 weeks* following dosage with a single chew.
Information on ordering Bravecto is available after login.
Presentation
Bravecto is a pork-flavoured chewable tablet presented in child resistant, foil wrapped, packs of either one or two tablets.
Active ingredients
Bravecto is an ectoparasiticide treatment for dogs that contains the active ingredient fluralaner.
Target species
Dogs
Indications for use
For the treatment of tick and flea infestations in dogs.
This veterinary medicinal product is a systemic insecticide and acaricide that provides:
- immediate and persistent flea (Ctenocephalides felis) killing activity for 12 weeks,
- immediate and persistent tick killing activity for 12 weeks for Ixodes ricinus, Dermacentor reticulatus and D. variabilis,
- immediate and persistent tick killing activity for 8 weeks for Rhipicephalus sanguineus.
- persistent tick killing activity from 7 days to 12 weeks after treatment for Ixodes hexagonus.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
For the treatment of demodicosis caused by Demodex canis.
For the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation.
For reduction of the risk of infection with Babesia canis canis via transmission by Dermacentor reticulatus for up to 12 weeks. The effect is indirect due to the veterinary medicinal product’s activity against the vector.
For reduction of the risk of infection with Dipylidium caninum via transmission by Ctenocephalides felis for up to 12 weeks. The effect is indirect due to the veterinary medicinal product’s activity against the vector.
Packaging
Bravecto is presented in child resistant packaging. It comes in a range of sizes to suit toy, small, medium and large dogs.
Legal Category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Date of preparation: January 2025
References
* Bravecto Chew provides 12-week immediate and persistent killing activity against fleas (Ctenocephalides felis), 12-week immediate and persistent killing activity against the ticks Ixodes ricinus, Dermacentor reticulatus and D. variabilis and 8-week immediate and persistent killing activity against Rhipicephalus sanguineus.